Skip to content

Thoraflex™ Hybrid THP2628X100ARecalls & reported problems

Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant

All models of Thoraflex Hybrid (33)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 05037881026701), received between Aug 27, 2024 and Jan 8, 2026 — classified as 2 injuries.

The most frequently reported specific device problem is “Device-Device Incompatibility” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 1 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device-Device Incompatibility1
  • Insufficient Device Problem Information1
  • Off-Label Use1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • Pseudoaneurysm1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 8, 2026Off-Label Use; Device-Device Incompatibility

    THE SUPER-STIFF GUIDEWIRE WAS LIKELY COILED WITHIN THE DESCENDING AORTA. DURING ATTEMPTED WITHDRAWAL, THE WIRE APPEARED TO BEND, WHICH IN TURN CAUSED DEFORMATION OF THE APPLICATOR TIP AND PREVENTED WIRE RETRIEVAL. A 44-YEAR-OLD MALE PATIENT PRESENTED WITH AN ACUTE TYPE A AORTIC DISSECTION. THE DEVICE WAS OPENED AND PREPARED IN ACCORDANCE WITH THE INSTRUCTIONS FOR USE (IFU). AN ANTEGRADE AMPLATZ SUPER-STIFF GUIDEWIRE WAS PLACED TO FACILITATE DELIVERY OF THE THORAFLEX HYBRID DEVICE. THE DEVICE WAS ADVANCED INTO POSITION, AND THE HANDLE WAS ACTUATED TO UNSHEATH THE STENT PORTION OF THE DEVICE. THE COLLAR HOLDER SUTURE WAS REMOVED AS PER STANDARD TECHNIQUE. UPON ATTEMPTED REMOVAL OF THE GUIDEWIRE, RESISTANCE WAS ENCOUNTERED, AND THE WIRE COULD NOT BE WITHDRAWN. THE SURGEON MADE MULTIPLE ATTEMPTS TO RETRIEVE THE WIRE; HOWEVER, IT WAS DETERMINED THAT THE WIRE HAD BECOME CAUGHT WITHIN THE DISTAL TIP OF THE APPLICATOR. INTRAOPERATIVE FINDINGS AND MANAGEMENT: THE SUPER-STIFF GUIDEWIRE WAS LIKELY COILED WITHIN THE DESCENDING AORTA. DURING ATTEMPTED WITHDRAWAL, THE WIRE APPEARED TO BEND, WHICH IN TURN CAUSED DEFORMATION OF THE APPLICATOR TIP AND PREVENTED WIRE RETRIEVAL. DUE TO THE INABILITY

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 24002710 ↗
  • InjuryAug 27, 2024Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    EVENT REPORTED FROM EXTEND-001 (NCT05639400) POST MARKET APPROVAL STUDY. THORAFLEX HYBRID PLEXUS WAS IMPLANTED IN A 52-YEAR-OLD (AT THE TIME OF CONSENT) MALE PATIENT, INDICATION FOR SURGERY: CHRONIC DISSECTION (DEBAKEY TYPE IIIB) AND POST-DISSECTION ANEURYSM. IMPLANT DATE (B)(6) 2024. EVENT DATE 31 JUL 24, 34 DAYS FROM PROCEDURE. NO SOURCE/MEDICAL NOTES HAVE BEEN UPLOADED INTO THE STUDY DATABASE FOR THIS EVENT SO FAR. THE SITE REPORTED THE EVENT OF PSEUDOANEURYSM (DESCRIPTION: INNOMINATE ARTERY PSEUDOANEURYSM) AS POSSIBLY RELATED TO THE THORAFLEX HYBRID DEVICE, RELATED TO THE PROCEDURE, AND NOT RELATED TO A PRE-EXISTING CONDITION. TREATMENT WAS REPORTED AS "STENT PLACEMENT-SUBCLAVIAN ARTERY". NOTE, NO DEVICE DEFICIENCY FORM HAS BEEN COMPLETED BY THE SITE TO DATE. THE OUTCOME HAS NOT YET BEEN PROVIDED IN THE STUDY DATABASE. THE SUBJECT REMAINS IN THE STUDY.

    Patient problems: Pseudoaneurysm

    MAUDE report 20074101 ↗

Other Hybrid stent graft, thoracic aortic lesion treatment devices

All Hybrid stent graft, thoracic aortic lesion treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page